Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Medtronic stent said to raise fatality risk in some cases

Medtronic stent said to raise fatality risk in some cases

19th March 2008

A stent manufactured by Medtronic has been claimed to increase the risk of fatality in some cases, it emerged this week.

The AneuRx stent, which is used to prevent aneurysms, may mean patients fitted with the device have a higher risk of death than those who opt for surgery, the US Food and Drug Administration (FDA) said.

It was found that when the mesh-wire tube is used, the patient is increasingly likely to suffer a fatal aneurysm, although it stated this was in “rare cases”.

New data from the FDA discovered 1.5 per cent of cases where the stent has been fitted for five years will die from this condition, which is above the 0.18 per cent rate of fatality for patients who underwent surgery.

However, it maintained that the risks vary greatly depending on the health and age of the patient. The FDA estimated a two per cent risk for a 70-year-old in good health, but up to a 40 per cent risk for a person with multiple health problems or organ damage.

Medtronic focuses on a range of therapeutic areas, including treatment for diabetes and Parkinson’s disease.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.